These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 30235938
1. Exosomal miR-1246 in body fluids is a potential biomarker for gastrointestinal cancer. Wei C, Li Y, Huang K, Li G, He M. Biomark Med; 2018 Oct; 12(10):1185-1196. PubMed ID: 30235938 [Abstract] [Full Text] [Related]
2. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, Xiang Y, Wu N, Wu L, Bai L, Li Y. Oncotarget; 2017 Feb 21; 8(8):13048-13058. PubMed ID: 28055956 [Abstract] [Full Text] [Related]
3. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma. Zhang W, Ni M, Su Y, Wang H, Zhu S, Zhao A, Li G. Eur Urol Focus; 2018 Apr 21; 4(3):412-419. PubMed ID: 28753793 [Abstract] [Full Text] [Related]
4. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Zhang X, Sai B, Wang F, Wang L, Wang Y, Zheng L, Li G, Tang J, Xiang J. Mol Cancer; 2019 Mar 13; 18(1):40. PubMed ID: 30866952 [Abstract] [Full Text] [Related]
5. Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung Adenocarcinoma. Han Z, Li Y, Zhang J, Guo C, Li Q, Zhang X, Lan Y, Gu W, Xing Z, Liang L, Li M, Mi S. Int J Med Sci; 2020 Mar 13; 17(10):1428-1438. PubMed ID: 32624699 [Abstract] [Full Text] [Related]
6. Circulating exosomal microRNAs as biomarkers of colon cancer. Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H, Watanabe M, Nakagama H, Yokota J, Kohno T, Tsuchiya N. PLoS One; 2014 Mar 13; 9(4):e92921. PubMed ID: 24705249 [Abstract] [Full Text] [Related]
7. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. Nedaeinia R, Manian M, Jazayeri MH, Ranjbar M, Salehi R, Sharifi M, Mohaghegh F, Goli M, Jahednia SH, Avan A, Ghayour-Mobarhan M. Cancer Gene Ther; 2017 Feb 13; 24(2):48-56. PubMed ID: 27982021 [Abstract] [Full Text] [Related]
8. Exosomal miR-23a and miR-192, Potential Diagnostic Biomarkers for Type 2 Diabetes. Liu C, Gao Y, Wu J, Zou J. Clin Lab; 2021 Feb 01; 67(2):. PubMed ID: 33616347 [Abstract] [Full Text] [Related]
9. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H, Zhu M, Shan X, Zhou X, Wang T, Zhang J, Tao J, Cheng W, Chen G, Li J, Liu P, Wang Q, Zhu W. Gene; 2019 Mar 01; 687():246-254. PubMed ID: 30458288 [Abstract] [Full Text] [Related]
10. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer. Shi Y, Wang Z, Zhu X, Chen L, Ma Y, Wang J, Yang X, Liu Z. Int J Clin Oncol; 2020 Jan 01; 25(1):89-99. PubMed ID: 31506750 [Abstract] [Full Text] [Related]
11. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells. Yoshimura A, Sawada K, Nakamura K, Kinose Y, Nakatsuka E, Kobayashi M, Miyamoto M, Ishida K, Matsumoto Y, Kodama M, Hashimoto K, Mabuchi S, Kimura T. BMC Cancer; 2018 Nov 05; 18(1):1065. PubMed ID: 30396333 [Abstract] [Full Text] [Related]
12. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer. Wang N, Wang L, Yang Y, Gong L, Xiao B, Liu X. Biochem Biophys Res Commun; 2017 Nov 25; 493(3):1322-1328. PubMed ID: 28986250 [Abstract] [Full Text] [Related]
13. Diagnostic value of microRNAs derived from exosomes in bronchoalveolar lavage fluid of early-stage lung adenocarcinoma: A pilot study. Kim JE, Eom JS, Kim WY, Jo EJ, Mok J, Lee K, Kim KU, Park HK, Lee MK, Kim MH. Thorac Cancer; 2018 Aug 25; 9(8):911-915. PubMed ID: 29806739 [Abstract] [Full Text] [Related]
14. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer. Su YY, Sun L, Guo ZR, Li JC, Bai TT, Cai XX, Li WH, Zhu YF. J Ovarian Res; 2019 Jan 22; 12(1):6. PubMed ID: 30670062 [Abstract] [Full Text] [Related]
15. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor. Warnecke-Eberz U, Chon SH, Hölscher AH, Drebber U, Bollschweiler E. Tumour Biol; 2015 Jun 22; 36(6):4643-53. PubMed ID: 25631748 [Abstract] [Full Text] [Related]
16. Exosomal microRNA: a novel biomarker for breast cancer. He Y, Deng F, Yang S, Wang D, Chen X, Zhong S, Zhao J, Tang J. Biomark Med; 2018 Feb 22; 12(2):177-188. PubMed ID: 29151358 [Abstract] [Full Text] [Related]
17. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data. Zhang Z, Pan B, Lv S, Ji Z, Wu Q, Lang R, He Q, Zhao X. Cell Physiol Biochem; 2018 Feb 22; 49(2):678-695. PubMed ID: 30165365 [Abstract] [Full Text] [Related]
18. Plasma exosome microRNAs are indicative of breast cancer. Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC, Ding WQ. Breast Cancer Res; 2016 Sep 08; 18(1):90. PubMed ID: 27608715 [Abstract] [Full Text] [Related]
19. Meta-analysis of the diagnostic value of exosomal miR-21 as a biomarker for the prediction of cancer. Liu F, Mao H, Chai S, Mao H. J Clin Lab Anal; 2021 Oct 08; 35(10):e23956. PubMed ID: 34492742 [Abstract] [Full Text] [Related]
20. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma. Takahasi K, Iinuma H, Wada K, Minezaki S, Kawamura S, Kainuma M, Ikeda Y, Shibuya M, Miura F, Sano K. J Hepatobiliary Pancreat Sci; 2018 Feb 08; 25(2):155-161. PubMed ID: 29130611 [Abstract] [Full Text] [Related] Page: [Next] [New Search]